The Consolidated Appropriations Act of 2023 (Omnibus) amended the Federal Food, Drug, and Cosmetic Act to require medical device manufacturers to address cybersecurity. As of March 29, 2023, they must provide cybersecurity details in premarket submissions. The Omnibus mandates plans for postmarket cybersecurity vulnerabilities, device cybersecurity demonstrations, and software bill of materials (SBOM) disclosures. Starting October 1, 2023, the FDA will reject submissions not meeting cybersecurity criteria, emphasizing proactive cybersecurity measures.
5 Questions about Wi-Fi 6E for Healthcare Workflows
Wi-Fi upgrades are essential in healthcare for secure, uninterrupted access to patient data, especially with increasing virtual care. Wi-Fi 6 offers high-efficiency, compatibility with earlier